Home / 2016 / October / 29 (page 6)

Daily Archives: Oct 29, 2016

Diabetes Research Platform

Which party do you believe will be a champion for diabetes research, prevention, and treatment? 1) Democrats 2) Republicans 3) Independents 4) None of the above 5) Not sure Follow the link to share your opinion and see what your colleagues think.

Read More »

Question 857

Test Your Knowledge

The new class of drugs, SGLT-2 Inhibitors, have been shown to have positive results; which one is false? 1. Reduces BP 2. Reduces Uric Acid 3. Reduces Glucagon 4. Reduces Glucose 5. Reduces Oxidative Stress 6. Reduces Hypotension 7. Reduces HF Risk Did you get the right answer? Follow the link to find out!

Read More »

Did You Know: What Are the SGLT-2 Inhibitor Trade-offs?

The overall profile of sodium-glucose cotransporter 2 inhibitors suggests they are a reliable, second-line therapy choice for adults with type 2 diabetes. However, the class is associated with possible side effects that should be carefully considered, according to a Dr. George L. Bakris, MD, director of the ASH Comprehensive Hypertension Center at the University of Chicago Medicine at a recent presentation at the Cardiometabolic Health Congress. Dr. Bakris stated that they definitely are preferred second-line agents, absolutely over sulfonylureas, and probably over thiazolidinediones and some other agents as well.

Read More »

Staff Physician

University of Virginia Location : Charlottesville VA US Physicians also share consulting physician responsibilities for nurse practitioners and physician assistants on staff…. More >> jobs by

Read More »